PERSPECTA

News from every angle

Back to headlines

Coherus Aims for $15M Quarterly LOQTORZI Sales by 2026

Coherus BioSciences is targeting $15 million in quarterly LOQTORZI sales by 2026, while also progressing with midyear readouts for tagmokitug and casdozokitug.

12 May, 13:52 — 12 May, 13:52
PostShare

Sources

Showing 1 of 1 sources